Page last updated: 2024-08-21

hydantoins and Parkinson Disease

hydantoins has been researched along with Parkinson Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, AM; Hofman, MA; Shan, L; Swaab Dick, F; Van Someren, EJ; van Wamelen, DJ	1
Eisenhofer, G; Harvey-White, J; Kirk, K; Kopin, IJ; Lamensdorf, I; Nechustan, A	1
Gehlen, W	1

Reviews

1 review(s) available for hydantoins and Parkinson Disease

Article	Year
[Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases]. Medizinische Klinik, 1977, Aug-12, Volume: 72, Issue:32-33 Topics: Amantadine; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Central Nervous System Diseases; Cerebrovascular Disorders; Chemical Phenomena; Chemistry; Contraceptives, Oral; Dihydroxyphenylalanine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydantoins; Mental Disorders; Nervous System Diseases; Parasympatholytics; Parkinson Disease; Pregnancy; Succinimides	1977

Article

Year

[Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases].

Medizinische Klinik, 1977, Aug-12, Volume: 72, Issue:32-33

Topics: Amantadine; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Central Nervous System Diseases; Cerebrovascular Disorders; Chemical Phenomena; Chemistry; Contraceptives, Oral; Dihydroxyphenylalanine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydantoins; Mental Disorders; Nervous System Diseases; Parasympatholytics; Parkinson Disease; Pregnancy; Succinimides

1977

Other Studies

2 other study(ies) available for hydantoins and Parkinson Disease

Article	Year
Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases. Sleep, 2012, May-01, Volume: 35, Issue:5 Topics: Alzheimer Disease; Case-Control Studies; Circadian Rhythm; Gene Expression; Histamine; Histidine; Humans; Huntington Disease; Hydantoins; Hypothalamic Area, Lateral; In Situ Hybridization; Neurodegenerative Diseases; Parkinson Disease	2012
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Brain research, 2000, Jun-23, Volume: 868, Issue:2 Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Dopamine; Energy Metabolism; Enzyme Inhibitors; Estrogens, Non-Steroidal; Fluorenes; Hydantoins; Isoflavones; Mitochondria; Neurons; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; PC12 Cells; Phenylethyl Alcohol; Rats; Rotenone	2000

Article

Year

Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases.

Sleep, 2012, May-01, Volume: 35, Issue:5

Topics: Alzheimer Disease; Case-Control Studies; Circadian Rhythm; Gene Expression; Histamine; Histidine; Humans; Huntington Disease; Hydantoins; Hypothalamic Area, Lateral; In Situ Hybridization; Neurodegenerative Diseases; Parkinson Disease

2012

3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.

Brain research, 2000, Jun-23, Volume: 868, Issue:2

Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Dopamine; Energy Metabolism; Enzyme Inhibitors; Estrogens, Non-Steroidal; Fluorenes; Hydantoins; Isoflavones; Mitochondria; Neurons; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; PC12 Cells; Phenylethyl Alcohol; Rats; Rotenone

2000